Abstract Background: The increasing demand for total knee arthroplasty (TKR) and the initiatives to reduce health care spending have put the responsibility for efficient care on hospitals and providers. Multidisciplinary care pathways have been shown to shorten length of stay and result in improved short-term outcomes. However, common problems such as post-op nausea, orthostasis, and quad weakness remain, while reliance on discharge to rehabilitation facilities may also prolong hospital stay. Questions/Purposes: Our aim was to document that combined modifications of our traditional clinical pathway for unilateral TKR could lead to improved short-term outcomes. We pose the following research questions. Can pathway modifications which include intra-articular infusion and saphenous nerve block (SNB) provide adequate pain relief and eliminate common side effects promoting earlier mobilization? Can planning for discharge to home avoid in-patient rehab stays? Can these combined modifications decrease length of stay even in patients with complex comorbidities indicated by higher ASA class? Will discharge to home incur an increase in complications or a failure to achieve knee range of motion? Patients and Methods: A retrospective review was performed and identified two cohorts. Group A included 116 patients that underwent unilateral TKR for osteoarthritis between August 2009 and August 2010. Group B included 171 patients that underwent unilateral TKR for osteoarthritis between February 2012 to February 2013. Group A patients were treated with spinal anesthesia with patient-controlled epidural analgesia (PCEA)/femoral nerve block (FNB) for the first 48 h after surgery. Discharge planning was initiated after admission. Group B had spinal anesthesia with SNB and received a continuous intra-articular infusion of 0.2% ropivicaine for 48 h post-op. Discharge planning was initiated with a case manager prior to hospitalization and discharge to home was declared the preferred approach. An intensive home PT program was made available through a program with our local home care agency. Outcomes assessed and compared between groups included length of stay, incidence of post-op nausea, dizziness, inhospital falls, occurrence of complications including wound infection and the recovery of range of motion at 6 weeks, 3 months, and 1 year post-op. Results: Pain control was similar between the groups but Group B had fewer side effects. With the new pathway, length of stay (LOS) was reduced from 4.32 to 3.64 days with a similar LOS reduction across all ASA classes. There was no increase in Group B wound or other complications. Return of ROM was similar between groups. Conclusions: Our findings suggest that replacing PCEA and FNB with intraarticular analgesia with a SNB allows for improved early recovery following TKR. That, combined with pre-op discharge planning and initiation of an intensive home PT program, reduced average length of stay.
procedures per year [5, 12, 21] . Even though TKR has been demonstrated to be a cost-effective procedure [14] , this surgical volume will become a major factor in health care costs incurred by Medicare beneficiaries. The Episodes of Care projects are contained in the Affordable Care Act of 2010. This initiative defines the total cost of care per beneficiary for any episodes of care and assigns responsibility to the treating hospital for that total cost which includes costs beginning the day before surgery until 30 days after surgery. This reimbursement structure will compel hospitals to develop coordinated systems of care that maximize efficiency and the quality of outcomes so that the overall cost per TKR is contained. To achieve this, hospitals will likely adopt multimodal clinical pathways for care which shorten hospital stay, minimize early complications that delay recovery and cause re-admissions, and perhaps most importantly plan discharge to home as opposed to acute rehabilitation or skilled nursing facilities. Previous studies have demonstrated that a comprehensive, multidisciplinary clinical pathway can meaningfully reduce length of stay after TKR [1, 13, 16] . In our experience [1] , we found that nausea, dizziness, and lower extremity weakness were common, and that many patients felt compelled to be discharged to acute rehab facilities. The approach to pain management within this pathway included preoperative administration of COX-2 inhibitor (meloxicam 15 mg po) and dexamethasone 6 mg po 1 h prior to surgery and relied exclusively on epidural patient controlled analgesia (PCA) as well as a single shot femoral nerve block (FNB) for postoperative analgesia complimented with oral narcotic medications administered as needed. Although very effective in preventing postoperative pain, we attributed the high frequency of side effects (40% of patients) and slow mobilization on post-op day 1 and 2 to the Epidural PCA. Although known to be very effective in controlling pain, epidural PCA is associated with several unwanted side effects including nausea in up to 50% of patients [2, 4] .
We concluded that in order to further reduce length of stay while improving the postoperative experience several additional modifications of our TKR clinical pathway were needed including alternatives to epidural analgesia and reduced reliance on narcotic analgesics. Encouraged by other reports we adopted the use of a continuous intra-articular infusion of local anesthetic in place of epidural PCA [7, 17, 18] . In order to allow earlier more aggressive mobilization we also replaced the femoral nerve block with a saphenous block to avoid quadriceps weakness and the potential for knee buckling and falls [6, 8, 10, 18, 20, 22] . Additional modifications to the clinical pathway included an emphasis on home discharge aided by a joint effort with our home care agency to provide daily physical therapy home visits for the first 2 weeks after discharge as an alternative to transfer to a acute rehabilitation facility.
These changes represent a multifaceted change in the approach to postoperative care for our TKR patients. The current study was performed to demonstrate that these modifications would (1) provide adequate pain relief to allow earlier post-op mobilization while avoiding the nausea and knee buckling associated with patient-controlled epidural analgesia (PCEA) and FNB; (2) decrease length of stay even in patients with complex comorbidities indicated by higher ASA class; (3) provide for a shorter length of stay while not leading to an increase in complications or need for readmission and (4) would achieve similar range of motion by 1 year follow-up.
Patients and Methods
A retrospective comparison of all patients diagnosed with osteoarthritis, who underwent a unilateral primary total knee replacement (TKR), in one surgeon's (CNC) practice was conducted. Three hundred and thirty consecutive patients were enrolled in the study between two time periods, August 31, 2009 to August 27, 2010 (Group A) and February 6, 2012 to February 4, 2013 (Group B) . No patients were excluded from either protocol. Group A consisted of 116 patients including 52 males and 64 females with a mean age of 68 years; and Group B consisted of 171 patients including 66 males and 105 females with a mean age of 68 years. The groups were similar in terms of pre-op condition Table 1 . Each group followed a specific but different clinical pathway. The two major differences in the pathways were the method of postoperative pain management and the adoption of an emphasis on discharge to home with physical therapy provided by a new program with our visiting nurse service. Group A was given a combined spinal and epidural anesthesia of bupivacaine (10-15 mg), FNB of 20-30 ml bupivacaine (0.25-0.5%), and an epidural infusion of bupivacaine (0.06%) and hydromorphone (10 μg/ml) at 4-8 ml/h for 48 h. Group B was given a spinal anesthestic of bupivacaine (10-15 mg), saphenous nerve block (SNB) of 8-10 ml bupivacaine (0.25-0.5%) and epinephrine (1:2,000,000), and an intra-articular catheter infusion of ropivacaine 0.2% at 7 ml/h for 48 h (Fig. 1) .
Demographics, age, length of stay (LOS), maximum pain scores (VASmax), ASA scores, discharge destination, and range of motion (ROM) were recorded for each followup visit (4-6 weeks, 3 months, 1 year). Adverse events including post-op syncope, nausea requiring treatment, vomiting, buckling, and falls were recorded into an excel database from hospital and patient charts.
Patients from both groups underwent similar preoperative diagnostic testing and medical clearance. Patients in both groups attended a pre-op class that reviewed procedures such as therapeutic exercises, pain management, useful equipment, expectations for functional recovery, length of stay, and the discharge process. Group B patient instructions were different in that they were informed that discharge to home was preferred to a rehab admission and that 5 day/week home PT sessions could be provided through the visiting nurse service in their community. Group B patients were also contacted by telephone for a preoperative case management discussion in which the discharge plan was agreed upon by the case manager and patient. During these discussions, the case managers reinforced the preference for home discharge unless the patient was elderly and infirm or living alone in an unsafe home environment. One hour prior to surgery, the patients were administered oral premedication including dexamethasone 6 mg, COX-2 inhibitor (meloxicam 15 mg), and ondansetron (Zofran 8 mg).
Group A patients underwent a combined spinal and epidural anesthesia with bupivacaine (10-15 mg) and were given a single injection femoral nerve block with 20-30 ml of bupivacaine (0.25-0.50%) and epinephrine (1:200,000). Patients in Group B were given a spinal anesthestic with bupivacaine (10-15 mg) and were given a saphenous nerve block with 8-10 ml bupivacaine (0.25-0.5%) and epinephrine (1:200,000). All patients received prophylatic IV antibiotics with cefazolin 2 g or vancomycin 1 g if they were penicillin allergic.
For the surgery, a tourniquet was applied and inflated to 250 mmHg. Standard posterior stabilized TKR was performed via a median parapatellar arthrotomy with a mid vastus extension. Patellar resurfacing was performed in all cases and all components were cemented with Simplex bone cement (Stryker Orthopedics, Mahwah, NJ). Group A patients' wounds were closed over a drain and Group B patients' wounds were closed over a pain catheter without a drain and 5 cm 3 of a fibrin spray (Evicel; OMRIX Biopharmaceuticals Ltd, Israel) was applied throughout the knee. For both groups, a running subcuticular wound closure using 3-0 monocryl was performed. After a bulky dressing was applied, patients in Group B had 20 ml of 0.5% of Marcaine injected through the intra-articular catheter prior to transfer to the post-anesthesia care unit.
During the postoperative phase, group A patients' were given an epidural infusion of bupivacaine (0.06%) and hydromorphone (10 μg/ml) at 4-8 ml/h for 48 h through a PCA machine for pain management. Patient demand was locked to limit hourly administration to a maximum of 20 ml. Group B patients were given an intra-articular catheter infusion of ropivacaine 0.2% at 7 ml/h for 48 h through a PCA machine. All patients were provided a continuous passive motion (CPM) machine in the post-anesthesia care unit (PACU), which was to be used for 2 h 3 times a day.
Patients were placed on Coumadin (goal INR 2.0) for DVT prophylaxis. Non-steroidal anti-inflammatory drug (toradol 15-30 mg IV) followed by meloxicam 15 mg orally was administered. Oral pain medication (Percocet 5-325 mg, Norco 5-325 mg, Tramadol 50 mg, or Nuycinta 50 mg) was given to the patient every 4 to 6 h, as needed to maintain VAS pain scores below 4-5. Group A patients were provided a Foley catheter and Group B patients were not. Patients were also provided physical therapy twice a day with instructions on mobilization while in the hospital and after discharge from the hospital. For both groups, the epidural, intra-articular catheter, drains, Foley catheter, and Jones dressing were all discontinued 48 h (postoperative day 2) after surgery. Maximum pain on the VAS was recorded as VASmax. Patients were noted to have buckling when performing physical therapy or walking in between physical therapy sessions. During such an event of buckling, each patient in the study was categorized as either a patient who did or did not experience buckling, regardless of the number of buckling events that occurred. Physical therapists, and/or nurses recorded the number of events of buckling into patient charts every day during the patients stay in the hospital postoperatively.
VASmax, narcotic consumption, LOS, ASA score, episodes of syncope/nausea/vomiting, knee buckling, falls, and destination of discharge were all obtained from nurses', anesthesiology, physical therapy, and case manager notes in the patient hospital charts. The VASmax was obtained from nurses' notes in the electronic hospital chart, in which a scale of 0 (no pain) to 10 (extreme amounts of pain) was used to determining pain levels the patient was feeling during the day. Oral narcotic intake by each patient was also obtained from the nurses' notes and converted to morphine equivalence (grams) using the conversion suggested by Krames [11] for comparison. For patients in Group A, we assumed the PCEA administered at least 10 μg hydromorphone/ml at 4 ml/h for 48 h. We therefore estimated that Group A patients received at least 1.9 mg of epidural hydromorphone from POD #0-2. Because the pharmacologic effects of epidural narcotic cannot be reliably converted to oral equivalents this epidurally administered narcotic was not converted and added to the total oral equivalents. It was just accepted that Group A received epidural narcotic while Group B did not. The episodes of syncope/nausea/vomiting were determined through nurses' notes and whether or not the patient requested medication for syncope/nausea/vomiting. The patient's LOS was recorded in days and obtained from hospital records. Patients' ASA scores were determined and recorded by the anesthesiologist on a scale of 1 (healthy patient) to 3 (healthy patient with moderate systemic diseases).
Follow-up visits were scheduled at 4-6 weeks, 3 months, and 1 year following surgery. During this time, the range of motion and any complications observed in the patients were recorded in the office charts. The surgeon's office charts were used to record the range of motion achieved at each follow-up visit as measured with a hand held goniometer. The number of manipulations, infections, and other complications (Table 2) were documented for each patient during the follow-up period.
Associations between categorical variables and protocol group were assessed with chi-squared and Fisher's exact tests. Differences in continuous variables between protocol groups were assessed with student's t tests or Mann Whitney U tests if non-normally distributed. Statistical tests were performed in SAS version 9.3 (Cary, NC, USA) with a level of significance of α=0.05. A Bonferroni corrections were used here to control the multiple test error-rate because these outcomes were tested at five different time points.
Results
The ropivicaine and SNB administered to Group B patients achieved equivalent pain control to the standard epidural and FNB (Group A) overall (Fig. 2) . Pain scores were higher (p<0.001) for Group B only on POD #1 but were equivalent for all other days from POD #0 to POD #5. Maximum mean VAS was 4.8 (±2.6) for Group B on POD #1 and 3.6 (±2.6) on POD #2 for Group A (Fig. 2) . On POD #0, average narcotic intake was higher for Group B (p=0.001) but for the rest of the hospitalization average oral narcotic was equivalent for both groups. However, Group B received no epidural hydromorphone (Fig. 3) . Patients in Group B experienced fewer episodes of buckling (p<0.001) (Fig. 4) as well as syncope (p<0.001) (Fig. 5) . There was no difference in the incidence of in-hospital falls. Group B patients also complained of less nausea (p<0.0001) and vomiting (p<0.001) requiring treatment (Fig. 6a, b) .
The modified clinical pathway administered to Group B reduced length of stay for all Group B patients (p<0.001) even in those patients with more complicated medical histories as indicated by ASA III classification (p=0.01). With the new pathway, LOS was reduced from 4.24 (±1.7) to 3.61 (±1) days. Length of stay was reduced regardless of baseline health status as judged from assigned ASA classification (Fig. 7) .
A difference in discharge destination of home versus rehab facility could not be demonstrated between the study groups. The incidence of infection was equivalent in both groups with superficial wound infections occurring in three patients in Group A and two patients in Group B. These superficial infections were resolved with short courses of PO antibiotics. During the first year follow-up period, one patient in each group suffered a deep prosthetic joint infection requiring 2-stage revision arthroplasty. One patient in Group B suffered a traumatic wound dehiscence from an injury occurring after hospital discharge. Incision and drainage was performed with avoidance of deep infection. The intra-articular catheter became trapped in one Group B patient and required arthroscopic removal on POD #3. Other complications occurred with no preponderance in either group (Table 1) .
At all time points of interest, the range of motion achieved by the patients in either group was equivalent (Fig. 8 ). There were no manipulations performed for poor range of motion in either group. 6 . Graphs documenting the percentage of patients in each group, Group A and B, which required treatment for nausea (a) (42% and 29% respectively) and vomiting (b) (32% and 25%, respectively).
Discussion
In this retrospective comparative review, we aimed to demonstrate that specific modifications of our existing clinical pathway for TKR which were based on our experience as well as recent literature reports [13, 16] could lead to improved short-term outcomes. Specifically, we adopted alternatives to address consistent problems such as nausea, dizziness, syncope, and quad weakness that we associated with the epidural analgesia combined with femoral nerve block. EPCA/FNB was substituted with saphenous nerve block with an intra-articular route for analgesia. We also addressed our traditional reliance on in-patient rehab by partnering with our regional home care agency to provide an intensive in-home rehab program as an alternative. These modifications provided for adequate pain management but allowed for a shorter length of stay, a greater percentage of home discharges, and fewer overall complications. The use of an intra-articular catheter over the first 48 h post-op was not associated with an increase in wound infections.
There are several limitations to our study. The change in the clinical pathway applied to Group B has multiple changes and the difference in outcome between the two groups cannot be ascribed to any single intervention. We believe the changes in combination represent a complete change in approach and that this global change is what is responsible for the observed differences. Although a shorter length of stay with a larger percentage of home discharges may result from a change in policy alone, we believe we have achieved this maintaining of improved outcomes without a sacrifice in quality or patient comfort. This is a retrospective observational study and as such selection bias and variability in data collection cannot be avoided. This is a single surgeon series so generalizations based on our observations must be made with caution. Some patients did have missing data due to the lack of entry in notes, missed follow-up visits, or missing records. This applied primarily to the 1-year follow-up ROM data in which qualitative statements regarding ROM were made rather than goniometer measurements. Goniometer measures were made in only 40% of the included cases. The comparison of ROM between groups included only those which had quantitative goniometer measures. We accept that goniometer measures are inherently imperfect but we are convinced that there was no clinically significant difference in range of motion between these two groups. For the purpose of comparison, we have converted the narcotic intake into oral morphine equivalents. We acknowledge that the incidence of nausea and other supraspinal effects of various narcotics may differ. Hydromorphone may result in less nausea than morphine. We have assumed the supraspinal effects to be similar in our comparison. Finally, some of our comparisons may have inadequate sample size. For example, although we did not note any difference in infection rate between our groups, infection rates are so low at our hospital that many thousands of patients would be required to assure an adequate sample size. Additionally, we experienced very few falls in either group. At HSS, we have an aggressive falls prevention program that indoctrinates the patients to never get out of bed without assistance during their hospital stay. Even though Group A experienced buckling few falls occurred and the one fall in Group B was the result of the patient violating the fall prevention doctrine. A much larger sample size is needed to accurately reflect any fall risk reduction.
This study adds to the growing body of evidence that Epidural PCEA and femoral nerve block delay recovery following TKR when compared to more peripheral administration of the analgesic agents [17, 18] . Femoral nerve blocks are now well known to be associated with prolonged quad weakness which slows the progression of post-op mobilization and increases the risk of falling during the hospital stay [6, 8, 10, 18, 20, 22] . Our current approach combines intra-articular infusion of ropivicaine with a saphenous nerve block. This study demonstrates that this approach provides excellent pain management as well as improved safety and overall patient comfort. The addition of the saphenous block improves post-op analgesia without increasing a risk of falls. Furthermore, the reduced consumption of narcotics in Group B patients may be the major factor leading to the reduced incidence of nausea, vomiting and dizziness that we observed in Group B. In a previous study [18] , we found ropivicaine infusion alone was associated with higher VAS pain scores during the first 48 h compared to Epidural/FNB. In this study, addition of the SNB has eliminated this difference. Rasmussen and colleagues [17] also noted the advantage of a continuous infusion of ropivicaine compared with single injection methods but they also added morphine to their infusion. The addition of morphine to the infusion may promote better pain control but may also increase the risk of side effects we wish to avoid. This will be the subject of future study at our institution.
We also attribute the shortened length of stay associated with our most recent clinical pathway to a more aggressive attempt to discharge patients home rather than to rehab facilities. Over the past decade, we have become increasingly discouraged by the administrative delay that is required for admission to rehab. We have always found a longer length of stay for patients transferred to facilities as opposed to going home. Furthermore, nothing in our experience suggested that outcomes were improved following an inpatient rehab experience. Several other studies document a similar experience and no study to date can demonstrate a long-term benefit of in-patient rehabilitation following total knee replacement [3, 9, 15, 19] . In this study, we clearly demonstrate that with the help of our home health care agency and the emphasis on home discharge during our pre-op education class and pre-op case management phone conference we could successfully discharge 75% of our patients to home with demonstrated reductions in early complications and no reduction in the achievement of early range of motion. This benefit was seen across all ASA grades. Our data suggests that even patients with more complicated medical status preoperatively can be effectively managed with a home care program following total knee replacement.
In summary, with this study we are able to confirm that multimodal pathway modifications that address factors which delay patient recovery can lead to improved rates of recovery reducing length of stay as well as short-term complications. Our past experience documented the advantages of a multimodal pathway for TKR [1] but we were hampered by early complications such as nausea, dizziness, syncope, and quad weakness with in-hospital falls. Furthermore, we found ourselves overly reliant on use of in-patient rehab which administratively prolonged hospital stay. Replacing the very effective but problematic epidural/FNB approach to analgesia with intra-articular ropivicaine and SNB, combined with an aggressive emphasis on home recovery has led to shorter length of stay with equivalent early return of range of motion and fewer post-op complications. As of 2014, the total cost per beneficiary will become an important metric affecting hospital reimbursement. One of the most significant but avoidable contributions to the total cost per beneficiary undergoing TKR is the added cost of in-patient rehabilitation. Although this study did not document a reduced discharge rate to rehab facilities, we did send most patients directly home without adverse consequences. This result allows us to more aggressively pursue a greater rate of direct home discharge in the future.
